Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.
Case Library Membership
Search free — but unlock advanced filters to find every case involving a specific company or clause.
Already a member? Sign in →
Case Library Membership
inc. VAT
inc. VAT · cancel any time
Secure payment via Stripe
Need access for your team?
Company licences available for compliance teams, medical affairs, and training programmes.
Get a team quote →1,930 cases found
Complaint alleged Google searches allowed public access to Bayer “advertisements” for medicines. Panel found documents were non-promotional or appropriately gated for HCPs.…
PMCPA ruled AstraZeneca’s Tagrisso Connect HCP site breached the Code because the first promotional pop-up lacked prescribing information and didn’t clearly signpost…
A UK-based GSK Global employee ‘celebrated’ a third-party LinkedIn post about promising niraparib results in glioblastoma. PMCPA found promotion to the public…
An events business employee posted a public X photo where “Invokana canagliflozin tablets” was legible on Menarini’s stand. PMCPA held this amounted…
A Sanofi Global employee’s LinkedIn job update included three product brand names and was liked/commented on by UK staff. Panel found the…
Complaint alleged Sun Pharma phone numbers and website were not functional, potentially affecting patient queries and side effect reporting. Panel found one…
Unapproved social posts and an NHS Trust web article recruiting for Moderna’s NextCOVE trial were found misleading and unclear about Moderna’s involvement.…
Complaint alleged Daiichi Sankyo’s sponsorship of an event wasn’t clear on the website home/registration pages. Panel found sponsorship disclosure and sponsor list…
Complaint alleged GSK sponsorship of an HCP event wasn’t disclosed on the homepage or registration pages. Panel found sponsorship was sufficiently clear…
Roche promotional materials for Vabysmo (faricimab) were ruled misleading where “first and only” wording and “may confer additional benefits” implied special clinical…
A UK-based Novartis employee ‘liked’ two LinkedIn posts referencing Cosentyx (secukinumab) and hidradenitis suppurativa. Panel ruled this proactively distributed POM promotion to…
A health professional complained that a patient accessed the Eylea SmPC via Bayer’s patient website. The Panel found the site appropriately separated…
AstraZeneca’s Trixeo HCP website mortality section was ruled misleading: prominent “46% risk reduction” and “across all treatment arms” messaging lacked clear context…
Novo Nordisk was ruled in breach for failures to disclose, late disclosure, and inaccurate/misplaced reporting of transfers of value to HCOs and…
CSL Vifor voluntarily admitted breaches after a global team sent a UK HCP an uncertified email invite/flyer for an overseas CKD-aP meeting…
Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.
